About the company
Cyclolab is a pioneer in cyclodextrin (CD) technology with 50 years of scientific experience in formulating new generation drugs.

During the last 25 years we have obtained experience in scientific, pre-clinical, and clinical studies creating subsequent analysis of post-clinical evidence-based medical therapy. This will allow our Partner to obtain information about analogy-free advantages compared to the TOP global drugs (including those currently in R&D stages), while being in the pre-contract period:
- 15 therapeutic areas/over 800 diseases
- 19 dosage forms

Comprehensive services for drafting the CTA and supporting interactions with the CRO for all phases of clinical trials.
Prior to finalizing the Agreement, we provide evidence-based analytics demonstrating the benefits of efficacy, safety, and exclusivity, along with independent patent purity assessments.
Unique solutions in therapy and safety
Offering a personalised relationship with the Customer:
COMPREHENSIVE SERVICES (incl. R&D and CDMO)
Customised and innovative solutions for scientific laboratories, universities, tender applicants and consulting R&D companies:

Customised and innovative solutions for scientific laboratories, universities, tender applicants and consulting R&D companies:
Comprehensive services for drafting the CTA and supporting interactions with the CRO for all phases of clinical trials.
Prior to finalizing the Agreement, we provide evidence-based analytics demonstrating the benefits of efficacy, safety, and exclusivity, along with independent patent purity assessments.
Purchase Of CD series
All productsOur analytical measurement services are designed to deliver accurate, reliable, and reproducible results—supporting every stage of your product development.
From raw material analysis to final batch release, we apply validated methods and state-of-the-art instrumentation to ensure regulatory compliance and scientific confidence.
Fine chemistry
products and custom synthesis
Cyclolab specializes in the synthesis of chemically modified carbohydrates, including single-isomer and statistically modified cyclodextrins, as well as innovative cross-linked CD polymers—both water-soluble and insoluble.
With expertise in protection/de-protection strategies, scaling-up processes, and GMP-considerate methods, we deliver fine chemicals tailored for advanced pharmaceutical and industrial applications.
Our analytical measurement services are designed to deliver accurate, reliable, and reproducible results—supporting every stage of your product development.
From raw material analysis to final batch release, we apply validated methods and state-of-the-art instrumentation to ensure regulatory compliance and scientific confidence.

TURNKEY SOLUTIONS
Comprehensive solutions from lab development to registration of next-generation drugs with no close analogues in efficacy, entering the global market for the first time.
Comprehensive
set of services
PROOF OF CONCEPT
Initial validation of therapeutic potential using unique Swiss and Cyclolab technologies to address unmet medical needs.
more...DISCOVERY PHASE
Development of disease-specific APIs guided by customized pharmaceutical strategies and R&D expertise.
more...PRE-CLINICAL PHASE
Simultaneous formulation development and pre-clinical studies to demonstrate efficacy and safety at early stages.
more...IND/CTA, CRO
Preparation of regulatory documentation and clinical trial applications in collaboration with CROs and customers.
more...CLINICAL TRIALS
Execution of all trial phases with advanced analytical support, guaranteeing predictable results and therapeutic impact.
more...TECHNOLOGY TRANSFER
End-to-end transfer of technology and processes to ensure regulatory-compliant, scalable commercial production.
more...PRODUCT REGISTRATION
Final product preparation for market entry through validated production, quality assurance, and regulatory alignment.
more...